Fusion Shipping FloSeal Hemostatic Sealant Following Dec. 8 FDA Approval
This article was originally published in The Gray Sheet
Executive Summary
Fusion Medical Technologies commenced shipments of its FloSeal hemostatic sealant on Dec. 9 at a price of $125 for a 4 ml kit, following FDA approval Dec. 8.
You may also be interested in...
Fusion Looking To Enter Cranial Surgery Sealant Market With Proceed Gel
Fusion Medical sees a $35 mil. market opportunity for the cranial indication of the firm's Proceed hemostatic sealant, based on a projected per-kit price of $140 and more than 240,000 cranial procedures performed worldwide annually.
Fusion Looking To Enter Cranial Surgery Sealant Market With Proceed Gel
Fusion Medical sees a $35 mil. market opportunity for the cranial indication of the firm's Proceed hemostatic sealant, based on a projected per-kit price of $140 and more than 240,000 cranial procedures performed worldwide annually.
Cohesion's CoStasis Surgical Hemostat To Ship In July, Gains FDA Approval
Tyco International's U.S. Surgical unit will market Cohesion Technologies' CoStasis liquid surgical hemostat. Shipments are expected to begin in early July.